Dr. Steven Green -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Steven Green, a Cardiology physician based in City, WA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Steven Green has received $1,869.68 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Steven Green has received a total of $1,869.68 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $1,869.68 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Steven Green's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription

The largest payment category for Dr. Steven Green is Speaking & Education, accounting for 0% ($0.00) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Steven Green. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Pfizer Inc$1,869.681

Dr. Steven Green has a financial relationship with Pfizer Inc, receiving $1,869.68 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

Drugs and Medical Devices Referenced in Payments

The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Steven Green. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.

The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Steven Green's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Steven Green has received $1.9K across 1 pharmaceutical payments as a Cardiology physician in City, WA. Top paying companies include Pfizer Inc ($1.9K). Received a single payment of $1870 in 2024. The entire payment came from Pfizer Inc. The payment was categorized as 'general' and associated with the drug Kisqali.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Steven Green is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consider asking your doctor about any potential conflicts of interest or if their recommendations are influenced by pharmaceutical relationships, especially when a significant portion of their payments come from a single source. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Steven Green Compares to Other Cardiology Physicians

As a Cardiologist, Dr. Green's payment profile is less diverse than many peers who engage with multiple pharmaceutical companies and a broader range of payment types.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Steven Green in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Pfizer Inc$1,869.68generalKisqali2024-05-20Not Assessed

Frequently Asked Questions About Dr. Steven Green's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Steven Green received?

Steven Green has received a total of $1.9K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Steven Green taking too much pharma money?

Steven Green has received $1.9K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Cardiology), the types of payments, and how they compare to peers. The largest payment category is general ($1.9K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Steven Green?

The top pharmaceutical companies paying Steven Green are: Pfizer Inc ($1.9K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Steven Green receive?

Steven Green's payments by type: general: $1.9K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Steven Green's payments compare to other Cardiology doctors?

To compare, look at the total amount ($1.9K), number of payments (1), and the types of payments received. Cardiology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Steven Green's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1043047590). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Steven Green's pharma payment profile?

The doctor has a single payment, making it difficult to establish a trend or diverse engagement. Steven Green has received $1.9K in total pharma payments.

How does Steven Green compare to peers in Cardiology?

As a Cardiologist, Dr. Green's payment profile is less diverse than many peers who engage with multiple pharmaceutical companies and a broader range of payment types.

Are Steven Green's pharma relationships typical for Cardiology?

100% of the total amount received is from a single company, indicating high company-specific reliance.

What should patients of Steven Green know about these payments?

Consider asking your doctor about any potential conflicts of interest or if their recommendations are influenced by pharmaceutical relationships, especially when a significant portion of their payments come from a single source.

What patterns are visible in Steven Green's payment history?

The payment is linked to a specific drug, Kisqali, suggesting a focused interaction.

Understanding This Doctor Payment Report

This transparency report for Dr. Steven Green is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Steven Green's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Steven Green and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.